| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |